Literature DB >> 22044122

Intranasal calcitonin reducing bone pain in a patient with Camurati-Engelmann disease.

A Trombetti, F Cortes, A Kaelin, M Morris, R Rizzoli.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 22044122     DOI： 10.3109/03009742.2011.608195

Source DB:  PubMed          Journal:  Scand J Rheumatol        ISSN： 0300-9742            Impact factor:   3.641


× No keyword cloud information.
  3 in total

Review 1.  Improvement of Bone Health and Initiation of Puberty Development in Camurati-Engelmann Disease With Glucocorticoid and Losartan Treatment: A Case Report and Review of Literature.

Authors:  Lijia Cui; Qian Li; Wenmin Guan; Wei Yu; Xiang Li; Weibo Xia; Yan Jiang
Journal:  Front Endocrinol (Lausanne)       Date:  2022-06-17       Impact factor: 6.055

2.  Role of TGF-β in a mouse model of high turnover renal osteodystrophy.

Authors:  Shiguang Liu; Wenping Song; Joseph H Boulanger; Wen Tang; Yves Sabbagh; Brian Kelley; Russell Gotschall; Susan Ryan; Lucy Phillips; Katie Malley; Xiaohong Cao; Tai-He Xia; Gehua Zhen; Xu Cao; Hong Ling; Paul C Dechow; Teresita M Bellido; Steven R Ledbetter; Susan C Schiavi
Journal:  J Bone Miner Res       Date:  2014       Impact factor: 6.741

Review 3.  [Calcitonin as an analgesic agent: review of mechanisms of action and clinical applications].

Authors:  Javad Yazdani; Reza Khorshidi Khiavi; Mohammad Ali Ghavimi; Ali Mortazavi; Elahe Jabbari Hagh; Farzin Ahmadpour
Journal:  Braz J Anesthesiol       Date:  2019-12-03
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.